Who benefits most from outpatient diuretic clinics?
Outpatient diuretic clinics appear most effective for older, frailer patients who are at high risk from full hospitalization. A 2025 study of a diuretic day hospital for patients over 70 (average age 84.7) found that all 8 patients completed their treatment without needing full hospitalization, with an average of 3.2 clinic sessions over about 8 days [2]. This suggests that for carefully selected elderly patients, outpatient IV diuretics can safely manage decompensation and avoid the risks of hospital admission.
However, the same study noted that patients often needed additional support: 62.5% went home with a home care provider, and 37.5% required home hospitalization for IV diuretics [2]. This means the clinic didn't work in isolation—it was part of a broader care network. So, the benefit is clearest when outpatient care is backed by home health services.
Does using the clinic actually reduce hospital visits?
The evidence is mixed, and the answer depends on how you measure success. A 2025 study of 657 patients in an ambulatory diuretic clinic found that as the number of clinic visits increased, the rate of heart failure hospitalizations also increased (adjusted rate ratio 1.09, meaning each additional visit was associated with a 9% higher hospitalization rate) [3]. This doesn't mean the clinic caused hospitalizations—rather, patients who needed more frequent outpatient diuresis were likely sicker and at higher risk. The clinic may have been managing their symptoms, but it couldn't prevent the underlying progression.
In contrast, a 2022 study of Medicare data found that patients who received IV diuretics in the emergency department had higher 30-day admission and mortality rates than those treated in outpatient settings [4]. This suggests that shifting care to outpatient settings may be safer than relying on the ED, but it doesn't prove that outpatient clinics reduce hospitalizations—it just shows they're associated with better outcomes than the ED.
What are the caveats and limitations?
The strongest evidence for benefit comes from a very small study (8 patients) [2], while the larger study (657 patients) shows a concerning association with more hospitalizations [3]. This discrepancy highlights that outpatient diuretic clinics are not a one-size-fits-all solution. They may work well for a select group—like the elderly in a structured program—but for a broader population, frequent clinic use may be a marker of high risk rather than a preventive measure.
Additionally, the 2022 Medicare study found that patients treated in the ED were older and had more chronic conditions than those treated as outpatients [4], which could explain the worse outcomes. So, while outpatient care appears safer than the ED, the comparison isn't apples-to-apples. Finally, a 2023 meta-analysis of in-hospital diuretic trials found no difference in decongestion or outcomes between ischemic and non-ischemic cardiomyopathy [1], suggesting that the underlying cause of heart failure may not influence how well diuretics work—but this was in-hospital, not outpatient.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2022 to 2025, 3 from 2024 or later, 4 in Q1 journals — selected as the most relevant from 5 studies that passed quality screening, drawn from 70 papers retrieved from a database of over 500 million.
Sources used in this answer
An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure
In a meta-analysis of 762 patients from three acute heart failure trials, there was no significant difference in decongestion or 60-day outcomes between ischemic and non-ischemic cardiomyopathy, suggesting that the cause of heart failure may not affect diuretic response.
Optimizing outpatient management of heart failure: the role of a diuretic day hospital in cardio-geriatrics
In an observational study of 8 elderly patients (mean age 84.7) at a diuretic day hospital, none required full hospitalization, with an average of 3.2 sessions and 7.7 days to complete decongestion, though many needed home care support.
Association Of Diuretic Infusions In An Outpatient Safety-net Diuretic Clinic With Number Of Subsequent Heart Failure Hospitalizations
In a cohort of 657 patients at an ambulatory diuretic clinic, each additional clinic visit was associated with a 9% higher rate of heart failure hospitalization (adjusted RR 1.09), indicating that frequent outpatient diuresis may be a marker of higher risk.
INTRAVENOUS DIURETIC ADMINISTRATION IN ALTERNATIVE CARE SETTINGS FOR THE MANAGEMENT OF HEART FAILURE: 30 DAY OUTCOMES
In a Medicare analysis of 1,534,708 IV diuretic encounters, patients treated in the emergency department had higher 30-day admission and mortality rates than those treated in outpatient settings, suggesting outpatient care may be safer than the ED.
Diuretic strategies in acute decompensated heart failure
A review of diuretic strategies in acute decompensated heart failure highlights that residual congestion at discharge increases readmission risk and that diuretic resistance is a major challenge, emphasizing the need for better decongestion strategies.